Clinician's Roundtable

Host: Bill Rutenberg, MD Guest: John Ruge, MD Successful brain surgery correlates with the amount of tumor removed. What if the neurosurgeon could visualize the tumor in situ during the operation? Join host, Dr. Bill Rutenberg, and his guest Dr. John Ruge, associate professor of neurosurgery at Rush Medical College and director of the Midwest Children's Brain Tumor Center. Dr. Ruge will discuss the novel technique of fluorescence-guided brain surgery. This technique, used in Germany for 10 years, has recently been brought to the U.S. by Dr. Ruge, who is also the first to apply it in pediatric neurosurgery.

Host: Maurice Pickard, MD Guest: James Webster, MD Despite dramatic improvement in American health and life expectancy over the past several decades, racial and ethnic minorities have not benefited equally from this progress. Dr. James Webster, professor of medicine at Northwestern University's Feinberg School of Medicine, and president of the Chicago Board of Health, discusses how improving cultural competence in health care workers can reduce disparities amongst patients. Dr. Maurice Pickard hosts.

Host: Bruce Bloom, DDS, JD Guest: Thomas Seyfried, PhD We almost always cure mice of cancer, but the same treatment often fails in humans. Is the problem the mouse model? Join host Dr. Bruce Bloom, and his guest, Dr. Thomas Seyfried, professor of biology at Boston College and associate editor of the Journal of Nutrition and Metabolism, as they review the first mouse model that manifests all the major hallmarks of human metastatic cancer.

Host: Leslie P. Lundt, MD Guest: David Servan-Schreiber, MD, PhD How much do nutrition, environmental factors, exercise, and psychoneuroimmunology play role in helping your patients prevent and manage cancer? Dr. David Servan-Schreiber, clinical professor of psychiatry at the University of Pittsburgh School of Medicine and cofounder of the Center for Integrative Medicine, joins host Dr. Leslie Lundt to discuss his ways to help prevent cancer.

Host: Leslie P. Lundt, MD Guest: Aaron Gibson, PharmD In an ideal world, evidence-based medicine and thoughtful clinical research might guide our every treatment decision. But the body of research is sparse on combination therapy for schizophrenia. When is it logical to combine antipsychotics? Dr. Aaron Gibson, assistant professor in the college of pharmacy at the University of New Mexico, joins host Dr. Leslie Lundt to explain when a combination might be reasonable and what problems might occur.

Host: Leslie P. Lundt, MD Guest: Eva Schernhammer, MD, DrPH Physicians' suicide rates are often reported as higher than the general population or of other academics. Dr. Eva Schernhammer, assistant professor of medicine at the Harvard Medical School and assistant professor of epidemiology at the Harvard School of Public Health, discusses her research into physician suicide with host Dr. Leslie Lundt.

Host: Leslie P. Lundt, MD Guest: Katharina Manassis, MD Children with the common presentation of both anxiety disorders and ADHD require a four-pronged treatment approach. What are the mainstays of treatment? Host Dr. Leslie Lundt welcomes Dr. Katharina Manassis, associate professor in the department of psychiatry at the University of Toronto, to discuss how to treat children with both ADHD and anxiety.

Host: Leslie P. Lundt, MD Guest: Robert E. Bristow, MD According to the American Cancer Society, over 21,000 new cases of ovarian cancer are diagnosed each year with 15,000 more women dying annually. What are the recent developments in research to improve these odds? Dr. Robert Bristow, the director of the Kelly Gynecologic Oncology Service and the Johns Hopkins Ovarian Cancer Center of Excellence, joins host Dr. Leslie Lundt to discuss the value of debulking surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer.

Host: Matthew J. Sorrentino, MD, FACC, FASH Guest: Jeanne Poole, MD Patients with advanced heart failure are at increased risk for sudden cardiac arrest, but many of them are not receiving ICD therapy. Dr. Jeanne Poole, professor of medicine and cardiology at the University of Washington, Seattle, will review with host Dr. Matthew Sorrentino the indications for ICD therapy in patients with congestive heart failure.

Host: Matthew J. Sorrentino, MD, FACC, FASH Guest: Jeanne Poole, MD Recent studies show that patients who receive an ICD shock, either appropriately or inappropriately, have a higher risk of death. Dr. Jeanne Poole, professor of Medicine and Cardiology at the University of Washington, Seattle shares with host, Dr. Matthew Sorrentino the prognostic importance of defibrillator shocks in patients with congestive heart failure.